Skip to content
Disclosery

TRV GP V, LLC

Follow

13F filer, CIK 1990717, Boston, MA

TRV GP V, LLC reported $429,165,290 across 3 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-051785

Period
2025-12-31
Reported value
$429M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001193125-26-051785, largest first. % of portfolio is the value over $429,165,290, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 7,135,233 shares; 2025Q1: 7,135,233 shares; 2025Q2: 7,135,233 shares; 2025Q3: 7,135,233 shares; 2025Q4: 7,135,233 shares 7,135,233$216M50.44%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 6,215,591 shares; 2025Q1: 6,215,591 shares; 2025Q2: 6,215,591 shares; 2025Q3: 6,215,591 shares; 2025Q4: 6,215,591 shares 6,215,591$173M40.38%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 950,800 shares; 2025Q2: 950,800 shares; 2025Q3: 950,800 shares; 2025Q4: 950,800 shares 950,800$39.4M9.18%0Timeline

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-051785 base2026-02-13acceptance time not in the bulk data set